大麻&ニコチン用インビトロ毒性アッセイの世界市場2021-2028:検査タイプ別、技術別、用途別(細胞毒性検査、遺伝子毒性検査)、方法別、地域別

【英語タイトル】In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Size, Share & Trends Analysis Report By Test Type, By Technology, By Application (Cytotoxicity Testing, Genetic Toxicity Testing), By Method, By Region, And Segment Forecasts, 2021 - 2028

Grand View Researchが出版した調査資料(GV21OT016)・商品コード:GV21OT016
・発行会社(調査会社):Grand View Research
・発行日:2021年10月6日
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(3営業日)
・調査対象地域:グローバル
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
グランドビューリサーチ社は、大麻&ニコチン用インビトロ毒性アッセイの世界市場規模が2028年までに29億ドルに達すると予測しています。2021年から2028年までの間に年平均11.2%成長する見通しです。本調査資料は、世界の大麻&ニコチン用インビトロ毒性アッセイ市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争状況、検査タイプ別(大麻検査、ニコチン検査)分析、方法別(細胞アッセイ、その他)分析、技術別(3D細胞培養技術、質量分析、フローサイトメトリー、その他)分析、用途別(遺伝子毒性検査、発がん性検査、細胞毒性検査、変異原性検査、その他)分析、地域別分析、競争分析などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・競争状況
・大麻&ニコチン用インビトロ毒性アッセイの世界市場規模:検査タイプ別(大麻検査、ニコチン検査)
・大麻&ニコチン用インビトロ毒性アッセイの世界市場規模:方法別(細胞アッセイ、その他)
・大麻&ニコチン用インビトロ毒性アッセイの世界市場規模:技術別(3D細胞培養技術、質量分析、フローサイトメトリー、その他)
・大麻&ニコチン用インビトロ毒性アッセイの世界市場規模:用途別(遺伝子毒性検査、発がん性検査、細胞毒性検査、変異原性検査、その他)
・大麻&ニコチン用インビトロ毒性アッセイの世界市場規模:地域別
・競争分析
【レポートの概要】

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Growth & Trends

The global in-vitro toxicology assays market size for cannabis and nicotine testing is expected to reach USD 2.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.2% from 2021 to 2028. Growing adoption of high throughput techniques in cannabis testing, legalization of medical cannabis, and growing awareness regarding the potential hazards of nicotine consumption have majorly driven the market throughout the forecast period.

The legalization of medical cannabis is underway globally, including in countries such as Germany, Australia, and Israel. The market is gaining momentum in the Asia Pacific region, with Thailand having fully legalized medicinal cannabis. Thus, increasing legalization of medical cannabis is expected to drive the market growth to a major extend. In addition, technological advancements in cellular assays have boosted the market growth.

COVID-19 has become a catalyst for changing the traditional use of cannabis. Owing to the pandemic, the leading scientific community and market competitors are now focusing on deciphering the potential of cannabis to prevent SARS-CoV-2 infection. Companies have reported the increase in the sale of cannabis as some states/countries have declared cannabis as an essential medicine during the pandemic.

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Report Highlights

• Nicotine testing accounted for the largest revenue in 2020 and is expected to continue the trend in the forecast period owing to increasing safety concerns associated with nicotine products

• Cannabis testing is expected to witness gradual growth through 2021-2028 owing to the rising acceptance of cannabis for medical use

• 3D cell culture technology is expected to grow at substantial CAGR owing to the increasing popularity of drug development and toxicity testing

• Cytotoxicity testing designing accounted for the highest market revenue in 2020 owing to advancements in different tools for evaluating the cytotoxic effects of nicotine-containing products

• North America has emerged as the highest revenue-generating region in 2020, owing to the prevalence of cancer, presence of key players, and developed healthcare infrastructure

• Asia Pacific is anticipated to witness the fastest CAGR throughout the forecast period. It is anticipated that China and India are contributing majorly to the regional market’s growth

• Key players are undertaking various strategic initiatives such as mergers and acquisitions to maintain their presence in the market

• In August 2020, Eurofins Scientific purchased approximately 136 smaller labs within 3 years from 2014 to 2019, accounting for a total expenditure of USD 3.4 billion in these acquisitions

【レポートの目次】

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Assumptions
1.2 Research Methodology
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.4.1 Market players:
1.4.4.2 Secondary data sources:
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation And Validation
1.7 Market Model
1.7.1 Model Details
1.7.1.1 Research approach
1.7.2 Revenue Share Assessment Of Technology Scope
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Summary, 2020
2.2 Market Segmentation
Chapter 3 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Usage Of Cannabis For Medicinal Purpose
3.2.1.2 Increasing Awareness Regarding The Potential Hazards Of Nicotine Consumption
3.2.1.3 Growing Adoption Of High Throughput Techniques In Cannabis Testing
3.2.2 Market Restraint Analysis
3.2.2.1 Suspension Of Nicotine-Based Products
3.2.2.2 Legalization Of Cannabis In Limited Countries
3.3 COVID-19 Impact Analysis: In vitro Toxicology Assays Market for Cannabis and Nicotine Testing
3.4 In Vitro Toxicology Assay Market for Cannabis and Nicotine Testing: Market Analysis Tools
3.4.1 Industry Analysis – Porter’s
3.4.2 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.4.3 Regulatory Framework
3.5 Penetration and Growth Prospect Mapping for Test Type, 2020
Chapter 4 Competitive Landscape
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Private Companies
4.3.1 List Of Key Private Companies
4.3.2 Strategy Framework Analysis
4.4 Stakeholders Landscape
4.4.1 List Of Key End-Users, Suppliers, And Competitors.
4.5 Major Deals & Strategic Alliances Analysis
4.5.1 Mergers & Acquisitions
4.5.2 Licensing & Partnership
4.5.3 Technology Collaborations
4.6 Regional Network Map
Chapter 5 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing: Test Type Business Analysis
5.1 In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Test Type Movement Analysis
5.2 Cannabis Testing
5.2.1 In Vitro Toxicology Market For Cannabis Testing, 2017 – 2028 (USD Million)
5.3 Nicotine Testing
5.3.1 In vitro toxicology market for nicotine testing, 2017 – 2028 (USD MILLION)
Chapter 6 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing: Method Business Analysis
6.1 Global In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Method Movement Analysis
6.2 Cellular Assay
6.2.1 Cellular Assay-Based In Vitro Toxicology Market For Cannabis & Nicotine Testing, 2017 – 2028 (USD Million)
6.2.1.1 Live Cells
6.2.1.2 Live Cell Assay-Based In Vitro Toxicology Market For Cannabis & Nicotine Testing, 2017 – 2028 (USD Million)
6.2.1.3 High-Throughput/High-Content Screening
6.2.1.3.1 High-Throughput/High-Content Screening -Based In Vitro Toxicology Market For Cannabis & Nicotine Testing, 2017 – 2028 (USD Million)
6.2.1.4 Molecular Imaging
6.2.1.4.1 Molecular Imaging -Based In Vitro Toxicology Market For Cannabis & Nicotine Testing, 2017 – 2028 (USD Million)
6.2.1.5 Others
6.2.1.5.1 Other Live Cell Imaging Technology -Based In Vitro Toxicology Market For Cannabis & Nicotine Testing, 2017 – 2028 (USD Million)
6.2.1.6 Fixed Cells
6.2.1.7 Fixed Cell Assay-Based In Vitro Toxicology Market For Cannabis & Nicotine Testing, 2017 – 2028 (USD Million)
6.3 Others
6.3.1 Other Assay-Based In Vitro Toxicology Market For Cannabis & Nicotine Testing, 2017 – 2028 (USD Million)
Chapter 7 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing: Technology Business Analysis
7.1 In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Technology Movement Analysis
7.2 3D Cell Culture Technology
7.2.1 3D Cell Culture Technology For In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 – 2028 (USD Million)
7.3 Mass Spectrometry
7.3.1 Mass Spectrometry Technology For In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 – 2028 (USD Million)
7.4 Flow Cytometry
7.4.1 Flow Cytometry Technology For In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 – 2028 (USD Million)
7.5 Others
7.5.1 Other Technologies For In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 – 2028 (USD Million)
Chapter 8 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing: Application Business Analysis
8.1 In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Application Movement Analysis
8.2 Genetic Toxicity Testing
8.2.1 Gene Toxicity Testing Application Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 – 2028 (USD Million)
8.3 Carcinogenicity Testing
8.3.1 Carcinogenicity Testing Application Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 – 2028 (USD Million)
8.4 Cytotoxicity Testing
8.4.1 Cytotoxicity Testing Application Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 – 2028 (USD Million)
8.5 Mutagenicity Testing
8.5.1 Mutagenicity Testing Application Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 – 2028 (USD Million)
8.6 Other Applications
8.6.1 Other Applications Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 – 2028 (USD Million)
Chapter 9 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing: Regional Business Analysis
9.1 In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Regional Movement Analysis
9.2 North America
9.2.1 U.S.
9.2.1.1 U.S. In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.2.1.2 U.S. In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.2.1.3 U.S. In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.2.1.4 U.S. In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.2.1.5 U.S. Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.2.1.6 U.S. Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.2.2 Canada
9.2.2.1 Canada In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.2.2.2 Canada In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.2.2.3 Canada In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.2.2.4 Canada In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.2.2.5 Canada Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.2.2.6 Canada Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.3.1.2 Germany In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.3.1.3 Germany In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.3.1.4 Germany In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.3.1.5 Germany Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.3.1.6 Germany Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.3.2 U.K.
9.3.2.1 U.K. In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.3.2.2 U.K. In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.3.2.3 U.K. In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.3.2.4 U.K. In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.3.2.5 U.K. Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.3.2.6 U.K. Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.3.3 France
9.3.3.1 France In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.3.3.2 France In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.3.3.3 France In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.3.3.4 France In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.3.3.5 France Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.3.3.6 France Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.3.4 Italy
9.3.4.1 Italy In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.3.4.2 Italy In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.3.4.3 Italy In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.3.4.4 Italy In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.3.4.5 Italy Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.3.4.6 Italy Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.3.5 Spain
9.3.5.1 Spain In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.3.5.2 Spain In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.3.5.3 Spain In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.3.5.4 Spain In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.3.5.5 Spain Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.3.5.6 Spain Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Japan In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.4.1.2 Japan In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.4.1.3 Japan In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.4.1.4 Japan In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.4.1.5 Japan Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.4.1.6 Japan Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million
9.4.2 China
9.4.2.1 China In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.4.2.2 China In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.4.2.3 China In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.4.2.4 China In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.4.2.5 China Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.4.2.6 China Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.4.3 India
9.4.3.1 India In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.4.3.2 India In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.4.3.3 India In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.4.3.4 India In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.4.3.5 India Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.4.3.6 India Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.4.4 Australia
9.4.4.1 Australia In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.4.4.2 Australia In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.4.4.3 Australia In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.4.4.4 Australia In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.4.4.5 Australia Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.4.4.6 Australia Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.4.5 Singapore
9.4.5.1 Singapore In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.4.5.2 Singapore In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.4.5.3 Singapore In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.4.5.4 Singapore In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.4.5.5 Singapore Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.4.5.6 Singapore Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Brazil In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.5.1.2 Brazil In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.5.1.3 Brazil In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.5.1.4 Brazil In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.5.1.5 Brazil Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.5.1.6 Brazil Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.5.2 Mexico
9.5.2.1 Mexico In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.5.2.2 Mexico In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.5.2.3 Mexico In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.5.2.4 Mexico In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.5.2.5 Mexico Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.5.2.6 Mexico Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.5.3 Argentina
9.5.3.1 Argentina In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.5.3.2 Argentina In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.5.3.3 Argentina In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.5.3.4 Argentina In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.5.3.5 Argentina Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.5.3.6 Argentina Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.6 Middle East And Africa
9.6.1 South Africa
9.6.1.1 South Africa In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.6.1.2 South Africa In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.6.1.3 In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.6.1.4 South Africa In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.6.1.5 South Africa Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.6.1.6 South Africa Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
9.6.2 Saudi Arabia
9.6.2.1 Saudi Arabia In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Test Type, 2017 – 2028 (USD Million)
9.6.2.2 Saudi Arabia In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology, 2017 – 2028 (USD Million)
9.6.2.3 Saudi Arabia In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Application, 2017 – 2028 (USD Million)
9.6.2.4 Saudi Arabia In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Method, 2017 – 2028 (USD Million)
9.6.2.5 Saudi Arabia Cellular Assay Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Imaging Method, 2017 – 2028 (USD Million)
9.6.2.6 Saudi Arabia Live Cell Imaging Based In-Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, By Technology 2017 – 2028 (USD Million)
Chapter 10 Competitive Profiling
10.1 Competitive Profiling
10.1.1 STEMINA BIOMARKER DISCOVERY, INC.
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 BROUGHTON NICOTINE SERVICES
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.3 LABSTAT INTERNATIONAL, INC.
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 IONTOX
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 TOXIKON
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 INTEGRATED LABORATORY SYSTEMS
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 ENTHALPY ANALYTICAL (ENTHALPY)
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 PBR LABORATORIES, INC.
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking

List of Tables

Table 1 The U.S. states, districts, and territories that have legalized either medical or recreational cannabis
Table 2 Countries with legal medical cannabis use
Table 3 Comparison between different cannabis testing methods
Table 4 Regulations on cannabis and nicotine products, by regions.
Table 5 List of key stakeholders
Table 6 Diversity of tobacco products
Table 7 Recommended methods for cannabis testing
Table 8 Cytotoxicity assays used for smokeless tobacco extracts
Table 9 Cytotoxicity assays used for cigarette smoke
Table 10 Types of low-THC cannabis-based products advertised for sale in the EU, Norway, and the U.K., February 2019
Table 11 Certified test facilities in India
Table 12 North America In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 13 North America In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 14 North America In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 15 North America In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 16 North America cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 17 North America live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 18 U.S. In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 19 U.S. In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 20 U.S. In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 21 U.S. In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 22 U.S. cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 23 U.S. live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 24 Canada In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 25 Canada In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 26 Canada In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 27 Canada In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 28 Canada cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 29 Canada live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 30 Europe In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 31 Europe In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 32 Europe In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 33 Europe In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 34 Europe cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 35 Europe live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 36 Germany In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 37 Germany In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 38 Germany In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 39 Germany In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 40 Germany cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 41 Germany live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 42 U.K. In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 43 U.K. In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 44 U.K. In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 45 U.K. In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 46 U.K. cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 47 U.K. live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 48 France In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 49 France In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 50 France In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 51 France In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 52 France cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 53 France live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 54 Italy In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 55 Italy In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 56 Italy In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 57 Italy In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 58 Italy cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 59 Italy live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 60 Spain In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 61 Spain In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 62 Spain In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 63 Spain In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 64 Spain cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 65 Spain live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 66 Asia Pacific In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 67 Asia Pacific In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 68 Asia Pacific In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 69 Asia Pacific In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 70 Asia Pacific cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 71 Asia Pacific live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 72 Japan In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 73 Japan In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 74 Japan In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 75 Japan In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 76 Japan cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 77 Japan live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 78 China In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 79 China In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 80 China In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 81 China In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 82 China cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 83 China live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 84 India In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 85 India In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 86 India In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 87 India In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 88 India cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 89 India live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 90 Australia In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 91 Australia In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 92 Australia In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 93 Australia In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 94 Australia cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 95 Australia live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 96 Singapore In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 97 Singapore In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 98 Singapore In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 99 Singapore In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 100 Singapore cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 101 Singapore live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 102 Latin In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 103 Latin America In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 104 Latin America In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 105 Latin America In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 106 Latin America cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 107 Latin America live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 108 Brazil In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 109 Brazil In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 110 Brazil In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 111 Brazil In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 112 Brazil cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 113 Brazil live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 114 Mexico In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 115 Mexico In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 116 Mexico In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 117 Mexico In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 118 Mexico cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 119 Mexico live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 120 Argentina In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 121 Argentina In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 122 Argentina In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 123 Argentina In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 124 Argentina cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 125 Argentina live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 126 MEA In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 127 MEA In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 128 MEA In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 129 MEA In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 130 MEA cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 131 MEA live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 132 South Africa In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 133 South Africa In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 134 South Africa In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 135 South Africa In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 136 South Africa cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 137 South Africa live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)
Table 138 Saudi Arabia In-vitro toxicology assays market for nicotine & cannabis testing, by test type, 2017 - 2028 (USD Million)
Table 139 Saudi Arabia In-vitro toxicology assays market for nicotine & cannabis testing, by technology, 2017 - 2028 (USD Million)
Table 140 Saudi Arabia In-vitro toxicology assays market for nicotine & cannabis testing, by application, 2017 - 2028 (USD Million)
Table 141 Saudi Arabia In-vitro toxicology assays market for nicotine & cannabis testing, by method, 2017 - 2028 (USD Million)
Table 142 Saudi Arabia cellular assay based In-vitro toxicology assays market for nicotine & cannabis testing, by imaging method, 2017 - 2028 (USD Million)
Table 143 Saudi Arabia live cell imaging based In-vitro toxicology assays market for nicotine & cannabis testing, by technology 2017 - 2028 (USD Million)



List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Methodology
Fig. 9 Research approach
Fig. 10 Parent market components
Fig. 11 Revenue share assessment of technology scope
Fig. 12 In vitro toxicology assays market for cannabis and nicotine testing snapshot, 2020 (USD Million)
Fig. 13 In vitro toxicology assays market for cannabis and nicotine testing segmentation
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five force analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Penetration and growth prospect mapping for test type, 2020
Fig. 19 Heat Map Analysis, by Key Market Participants
Fig. 20 Participant categorization – In vitro toxicology assay market for cannabis and nicotine testing
Fig. 21 Private Company Market Position Analysis, 2020
Fig. 22 Regional Network Map
Fig. 23 Global In vitro toxicology assays market for cannabis and nicotine testing: Test type outlook key takeaways (USD Million)
Fig. 24 Global In vitro toxicology assays market for cannabis and nicotine testing: Test type movement analysis
Fig. 25 In vitro toxicology market for cannabis testing, 2017 - 2028 (USD Million)
Fig. 26 In vitro toxicology market for nicotine testing, 2017 - 2028 (USD Million)
Fig. 27 Global In vitro toxicology assays market for cannabis and nicotine testing: Method outlook key takeaways (USD Million)
Fig. 28 In vitro toxicology assays market for cannabis and nicotine: Method movement analysis
Fig. 29 Cellular assay-based In vitro toxicology market for cannabis & nicotine testing, 2017 - 2028 (USD Million)
Fig. 30 Live cell -based In vitro toxicology market for cannabis & nicotine testing, 2017 - 2028 (USD Million)
Fig. 31 High-throughput/high-content screening -based In vitro toxicology market for cannabis & nicotine testing, 2017 - 2028 (USD Million)
Fig. 32 Molecular imaging -based In vitro toxicology market for cannabis & nicotine testing, 2017 - 2028 (USD Million)
Fig. 33 Other live cell imaging technology -based In vitro toxicology market for cannabis & nicotine testing, 2017 - 2028 (USD Million)
Fig. 34 Fixed cell -based In vitro toxicology market for cannabis & nicotine testing, 2017 - 2028 (USD Million)
Fig. 35 Other assay-based In vitro toxicology market for cannabis & nicotine testing, 2017 - 2028 (USD Million)
Fig. 36 In-Vitro toxicology assays market for nicotine & cannabis testing: Technology outlook and key takeaways
Fig. 37 In vitro toxicology assays market for nicotine & cannabis testing: Technology movement analysis
Fig. 38 3D cell culture technology for in vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 39 Mass spectrometry technology for in vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 40 Flow cytometry technology for in vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 41 Other technologies for in vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 42 In-Vitro toxicology assays market for nicotine & cannabis testing: Application outlook and key takeaways
Fig. 43 In vitro toxicology assays market for nicotine & cannabis testing: Application movement analysis
Fig. 44 Genetic toxicity testing application of In vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 45 Carcinogenicity testing application of In vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 46 Cytotoxicity testing application of In vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 47 Mutagenicity testing application of In vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 48 Other applications of In vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 49 In-Vitro toxicology assays market for nicotine & cannabis testing: Regional outlook
Fig. 50 In vitro toxicology assays market for nicotine & cannabis testing: Regional movement analysis
Fig. 51 North America In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 52 U.S. In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 53 Canada In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 54 Europe In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 55 Germany In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 56 U.K. In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 57 France In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 58 Italy In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 59 Spain In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 60 Asia Pacific In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 61 Japan In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 62 China In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 63 India In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 64 Australia In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 65 Singapore In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 66 Latin America In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 67 Brazil In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 68 Mexico In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 69 Argentina In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 70 Middle East & Africa In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 71 South Africa In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)
Fig. 72 Saudi Arabia In-vitro toxicology assays market for nicotine & cannabis testing, 2017 - 2028 (USD Million)

★調査レポート[大麻&ニコチン用インビトロ毒性アッセイの世界市場2021-2028:検査タイプ別、技術別、用途別(細胞毒性検査、遺伝子毒性検査)、方法別、地域別] (コード:GV21OT016)販売に関する免責事項を必ずご確認ください。
★調査レポート[大麻&ニコチン用インビトロ毒性アッセイの世界市場2021-2028:検査タイプ別、技術別、用途別(細胞毒性検査、遺伝子毒性検査)、方法別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆